Upgrade to SI Premium - Free Trial

AbCellera Biologics (ABCL) PT Raised to $12 at Truist Securities

May 22, 2026 7:05 AM
(Updated - May 22, 2026 9:20 AM EDT)

Truist Securities analyst Srikripa Devarakonda raised the price target on AbCellera ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change